Clinical outcomes of patients hospitalized for COVID-19 and evidence-based on the pharmacological management reduce mortality in a region of the Colombian Caribbean
Mara García-Posada, Sandra Aruachan-Vesga, Danis Mestra, Katherine Humánez, Héctor Serrano-Coll, Heriberto Cabrales, Álvaro Faccini, Salim Mattar
Journal of Infection and Public Health, doi:10.1016/j.jiph.2021.02.013
Introduction: Despite the high volume of infections, some clinical aspects of this disease are still unknown. There are currently no studies in Colombia that describe the disease's clinical and treatment aspects in detail. Objective: Describe the characteristics and clinical management of a group of admitted patients with SARS-CoV-2 infection in a private clinic in Montería, Córdoba-Colombia. Patients and methods: A descriptive observational study was carried out between May and August 2020 in 209 hospitalized patients with a confirmed diagnosis of COVID-19. Upon admittance, clinical, sociodemographic characteristics, comorbidities, and complications were analyzed. Additionally, the effect of the following medications was described: 1-antibiotics (cefepime, piperacillin, tazobactam, meropenem, vancomycin) + low molecular weight heparin (LMWH) + corticosteroids (dexamethasone-methylprednisolone) + colchicine. 2-Antibiotic + LMWH + corticosteroids. 3-LMWH + corticosteroids. 4-LMWH + corticosteroids + colchicine. 5-Other treatments (Tocilizumab). Results: 107 (51%) of the 209 patients with a confirmed diagnosis of COVID-19 passed away. The main comorbidities related to mortality of these hospitalized patients with COVID-19 were obesity and kidney disease (P < 0.05). The main complications associated with fatal outcomes in this group of patients were Acute Respiratory Distress Syndrome (ARDS) and sepsis (P < 0.05). Furthermore, it was evidenced that the colchicine combination showed a significant difference in reducing mortality in hospitalized patients compared to the other therapeutic regimens (P < 0.05). Conclusion: A mortality rate of 51% was found attributable to several factors such as advanced age, obesity, kidney disease, and an average time in days of late consultation. The implementation of the colchicine combination could reduce the mortality rate in this disease.
Competing interests None declared.
Ethical approval This research was approved by the ethics and research committee of Oncomedica S.A.
References
Ayerbe, Risco, Ayis, The association between treatment with heparin and survival in patients with Covid-19, J Thromb Thrombolysis
Carlson, Nelveg-Kristensen, Ballegaard, Feldt-Rasmussen, Hornum et al., Increased vulnerability to Covid-19 in chronic kidney disease, J Intern Med
Chang, Chan, Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics, J Infect
Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet
Cui, Chen, Li, Liu, Wang, Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia, J Thromb Haemost
De Souza, Buss, Da S Candido, Carrera, Li et al., Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil, Nat Hum Behav
Deftereos, Giannopoulos, Vrachatis, Siasos, Giotaki et al., Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial, JAMA Netw Open
Goyal, Choi, Pinheiro, Schenck, Chen et al., Clinical characteristics of covid-19 in New York City, N Engl J Med
Guan, Ni, Hu, Liang, Ou et al., Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med
Han, Shi, Xie, Zhang, Huang et al., Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration, Epidemiol Infect
Ins, Covid, -19 en Colombia
Jiménez, Vela, Valencia, Fernandez-Jimenez, Álvaro-Alonso et al., Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study, BMJ Open
Klok, Kruip, Van Der Meer, Arbous, Gommers et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res
Lansbury, Lim, Baskaran, Lim, Co-infections in people with COVID-19: a systematic review and meta-analysis, J Infect,
doi:10.1093/cid/ciaa530Middeldorp, Coppens, Van Haaps, Foppen, Vlaar et al., Incidence of venous thromboembolism in hospitalized patients with COVID-19, J Thromb Haemost
Mohamed, Benn, Astha, Okhawere, Korn et al., Association between chronic kidney disease and COVID-19-related mortality in New York, World J Urol,
doi:10.1007/s00345-020-03567-4Ortiz-Brizuela, Villanueva-Reza, González-Lara, Tamez-Torres, Montes et al., Clinical and epidemiological characteristics of patients diagnosed with covid-19 in a tertiary care center in Mexico City: a prospective cohort study, Rev Investig Clin organo del Hosp Enfermedades la Nutr
Ozturk, Turgutalp, Arici, Odabas, Altiparmak et al., Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey, Nephrol Dial Transplant
Panigada, Bottino, Tagliabue, Grasselli, Novembrino et al., Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis, J Thromb Haemost
Parra-Bracamonte, Parra-Bracamonte, Lopez-Villalobos, Al, Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico, Nephrology,
doi:10.1007/s00345-020-03567-4Ranucci, Ballotta, Dedda, Bayshnikova, Poli et al., The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome, J Thromb Haemost
Rawson, Moore, Zhu, Ranganathan, Skolimowska et al., Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing, Clin Infect Dis,
doi:10.1093/cid/ciaa530Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA,
doi:10.1001/jama.2020.6775Rodriguez-Nava, Yanez-Bello, Garcia, Chung, Chaudry et al., Clinical characteristics and risk factors for mortality of hospitalized patients with COVID-19 in a community hospital: a retrospective cohort study, Mayo Clin Proc Innov Qual Outcomes
Roozenbeek, Schneider, Dryhurst, Kerr, Freeman et al., Susceptibility to misinformation about COVID-19 around the world, R Soc Open Sci,
doi:10.1016/S1473-3099Sattar, Mcinnes, Mcmurray, Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms, Circulation
Sharma, Garg, Rout, Lavie, Association of obesity with more critical illness in COVID-19, Mayo Clinic Proc
Tamara, Tahapary, Obesity as a predictor for a poor prognosis of COVID-19: a systematic review, Diabetes Metab Syndr
Tang, Bai, Chen, Gong, Li et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost
Trujillo, Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud Recomendaciones basadas en consenso de expertos e informadas en la evidencia
Tzotzos, Fischer, Fischer, Zeitlinger, Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey, Crit Care
Wang, Du, Zhu, Cao, An et al., Comorbidities and multi-organ injuries in the treatment of COVID-19, Lancet
Wang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA
Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med,
doi:10.1001/jamainternmed.2020.0994Xiong, Liu, Lin, Shi, Han et al., Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study, BMC Infect Dis
Yang, Sheng, Huang, Jin, Xiong et al., Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study, Lancet Oncol
Zangrillo, Beretta, Scandroglio, Monti, Fominskiy et al., Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy, Crit care Resusc J Australas Acad Crit Care Med
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
